Dentsply Sirona (XRAY)

Nasdaq Health Care Health Care Supplies S&P MidCap 400

$9.46

-0.63 (-6.24%)

Close of Nov 06, 2026 · end-of-day data

Source: Dentsply Sirona's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$0	$3.99B	$3.99B	$4.02B	$3.34B	$4.23B	$3.92B	$3.96B	$3.79B	$3.68B
Cost of revenue	$1.74B	$1.80B	$1.92B	$1.86B	$1.68B	$1.88B	$1.79B	$1.88B	$1.83B	$1.84B
Gross profit	$2.00B	$2.19B	$2.07B	$2.16B	$1.66B	$2.35B	$2.13B	$2.09B	$1.96B	$1.84B
Research & development	$128.50M	$151.70M	$161.00M	$143.00M	$123.00M	$171.00M	$174.00M	$184.00M	$165.00M	$150.00M
Selling, general & admin	$1.52B	$1.67B	$1.72B	$1.59B	$1.30B	$1.55B	$1.59B	$1.61B	$1.60B	$1.44B
Operating income	$454.70M	-$1.56B	-$958.00M	$353.00M	-$3.00M	$608.00M	-$937.00M	-$85.00M	-$879.00M	-$422.00M
Interest expense	$35.90M	$38.30M	$37.00M	$30.00M	$48.00M	$61.00M	$65.00M	$81.00M	$69.00M	$88.00M
Pre-tax income	$440.90M	-$1.60B	-$958.00M	$338.00M	-$50.00M	$545.00M	-$1.05B	-$175.00M	-$936.00M	-$486.00M
Income tax	$9.50M	-$53.20M	$53.00M	$82.00M	$23.00M	$134.00M	-$105.00M	-$43.00M	-$26.00M	$112.00M
Net income	$429.90M	-$1.55B	-$1.01B	$256.00M	-$73.00M	$411.00M	-$950.00M	-$132.00M	-$910.00M	-$598.00M
EBITDA	$726.40M	-$1.25B	-$627.00M	$676.00M	$331.00M	$955.00M	-$609.00M	$258.00M	-$530.00M	-$70.00M
EPS (basic)	$1.97	$-6.76	$-4.51	$1.15	$-0.33	$1.88	$-4.41	$-0.62	$-4.48	$-3.00
EPS (diluted)	$1.94	$-6.76	$-4.51	$1.14	$-0.33	$1.87	$-4.41	$-0.62	$-4.48	$-3.00
Diluted shares	221.60M	229.40M	224.30M	224.40M	219.20M	220.20M	215.50M	212.00M	203.20M	199.40M
Gross margin	—	54.8%	51.9%	53.8%	49.6%	55.5%	54.2%	52.6%	51.6%	50.0%
Operating margin	—	-39.1%	-24.0%	8.8%	-0.1%	14.4%	-23.9%	-2.1%	-23.2%	-11.5%
Net margin	—	-38.8%	-25.4%	6.4%	-2.2%	9.7%	-24.2%	-3.3%	-24.0%	-16.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$383.90M	$320.60M	$309.60M	$405.00M	$438.00M	$339.00M	$365.00M	$334.00M	$272.00M	$326.00M
Inventory	$517.10M	$623.10M	$598.90M	$562.00M	$476.00M	$515.00M	$627.00M	$624.00M	$564.00M	$642.00M
Total current assets	$1.74B	$2.00B	$1.89B	$2.00B	$1.80B	$1.85B	$1.89B	$1.97B	$1.75B	$2.02B
Goodwill	$5.95B	$4.54B	$3.43B	$3.40B	$3.99B	$3.98B	$2.69B	$2.44B	$1.60B	$1.15B
Total assets	$11.56B	$10.37B	$8.69B	$8.60B	$9.35B	$9.24B	$7.64B	$7.37B	$5.75B	$5.43B
Total current liabilities	$767.60M	$954.50M	$1.01B	$995.00M	$1.37B	$1.26B	$1.17B	$1.43B	$1.59B	$1.34B
Short-term debt	$21.10M	$30.10M	$92.40M	$2.00M	$299.00M	$182.00M	$118.00M	$322.00M	$549.00M	$313.00M
Long-term debt	$1.51B	$1.61B	$1.56B	$1.43B	$1.98B	$1.91B	$1.83B	$1.80B	$1.59B	$2.02B
Total debt	$1.53B	$1.64B	$1.66B	$1.44B	$2.28B	$2.10B	$1.94B	$2.12B	$2.13B	$2.33B
Total liabilities	$3.43B	$3.75B	$3.55B	$3.51B	$4.42B	$4.24B	$3.83B	$4.08B	$3.81B	$4.09B
Shareholders' equity	$8.11B	$6.62B	$5.12B	$5.09B	$4.93B	$5.00B	$3.81B	$3.29B	$1.94B	$1.34B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$563.40M	$601.90M	$500.00M	$639.00M	$649.00M	$657.00M	$517.00M	$377.00M	$461.00M	$235.00M
Capital expenditures	$125.00M	$144.30M	$183.00M	$123.00M	$87.00M	$142.00M	$149.00M	$149.00M	$180.00M	$131.00M
Free cash flow	$438.40M	$457.60M	$317.00M	$516.00M	$562.00M	$515.00M	$368.00M	$228.00M	$281.00M	$104.00M
Investing cash flow	$60.00M	-$286.40M	-$253.00M	-$69.00M	-$1.11B	-$358.00M	-$138.00M	-$89.00M	-$197.00M	-$132.00M
Financing cash flow	-$526.20M	-$400.80M	-$250.00M	-$472.00M	$476.00M	-$379.00M	-$329.00M	-$307.00M	-$302.00M	-$80.00M
Dividends paid	$64.60M	$78.30M	$79.00M	$81.00M	$88.00M	$92.00M	$104.00M	$116.00M	$126.00M	$128.00M
Share buybacks	$813.90M	$401.40M	$250.00M	$260.00M	$140.00M	$200.00M	$150.00M	$300.00M	$250.00M	$0
Stock-based compensation	$41.30M	$48.00M	$21.00M	$66.00M	$47.00M	$48.00M	$59.00M	$46.00M	$39.00M	$33.00M
Depreciation & amortization	$271.70M	$316.40M	$331.00M	$323.00M	$334.00M	$347.00M	$328.00M	$343.00M	$349.00M	$352.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$1.01B	$953.00M	$984.00M	$951.00M	$905.00M	$879.00M	$936.00M	$904.00M	$961.00M	$880.00M	$898.00M	$836.00M
Cost of revenue	$490.00M	$447.00M	$473.00M	$456.00M	$459.00M	$413.00M	$446.00M	$463.00M	$518.00M	$453.00M	$405.00M	$393.00M
Gross profit	$522.00M	$506.00M	$511.00M	$495.00M	$446.00M	$466.00M	$490.00M	$441.00M	$443.00M	$427.00M	$493.00M	$443.00M
Research & development	$43.00M	$42.00M	$41.00M	$40.00M	$42.00M	$36.00M	$37.00M	$37.00M	$40.00M	$44.00M	$45.00M	$42.00M
Selling, general & admin	$409.00M	$415.00M	$399.00M	$390.00M	$401.00M	$358.00M	$342.00M	$355.00M	$383.00M	$351.00M	$364.00M	$363.00M
Operating income	$73.00M	$42.00M	$50.00M	-$462.00M	-$509.00M	$63.00M	-$128.00M	-$218.00M	-$139.00M	-$35.00M	$82.00M	$37.00M
Interest expense	$23.00M	$18.00M	$17.00M	$18.00M	$16.00M	$19.00M	$24.00M	$23.00M	$22.00M	$24.00M	$22.00M	$25.00M
Pre-tax income	$57.00M	$31.00M	$34.00M	-$478.00M	-$523.00M	$44.00M	-$153.00M	-$230.00M	-$147.00M	-$42.00M	$72.00M	$26.00M
Income tax	-$15.00M	$14.00M	$38.00M	$17.00M	-$95.00M	$25.00M	-$109.00M	$198.00M	-$2.00M	-$32.00M	$36.00M	$29.00M
Net income	$67.00M	$18.00M	-$4.00M	-$494.00M	-$430.00M	$20.00M	-$45.00M	-$427.00M	-$146.00M	-$10.00M	$37.00M	-$2.00M
EBITDA	$106.00M	$128.00M	$136.00M	-$373.00M	-$421.00M	$142.00M	-$40.00M	-$126.00M	-$46.00M	$44.00M	$167.00M	$119.00M
EPS (basic)	$0.32	$0.09	$-0.02	$-2.46	$-2.13	$0.10	$-0.22	$-2.14	$-0.73	$-0.05	$0.18	$-0.01
EPS (diluted)	$0.32	$0.09	$-0.02	$-2.46	$-2.13	$0.10	$-0.22	$-2.14	$-0.73	$-0.05	$0.18	$-0.01
Diluted shares	-700.00K	208.50M	205.60M	201.00M	-1.50M	199.80M	199.30M	199.50M	100.00K	199.90M	200.50M	199.20M
Gross margin	51.6%	53.1%	51.9%	52.1%	49.3%	53.0%	52.4%	48.8%	46.1%	48.5%	54.9%	53.0%
Operating margin	7.2%	4.4%	5.1%	-48.6%	-56.2%	7.2%	-13.7%	-24.1%	-14.5%	-4.0%	9.1%	4.4%
Net margin	6.6%	1.9%	-0.4%	-51.9%	-47.5%	2.3%	-4.8%	-47.2%	-15.2%	-1.1%	4.1%	-0.2%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$334.00M	$291.00M	$279.00M	$296.00M	$272.00M	$398.00M	$359.00M	$363.00M	$326.00M	$190.00M	$239.00M	$195.00M
Inventory	$624.00M	$613.00M	$608.00M	$619.00M	$564.00M	$612.00M	$675.00M	$686.00M	$642.00M	$659.00M	$665.00M	$707.00M
Total current assets	$1.97B	$1.90B	$1.76B	$1.92B	$1.75B	$1.98B	$1.97B	$2.07B	$2.02B	$1.84B	$1.93B	$1.98B
Goodwill	$2.44B	$2.40B	$2.39B	$1.94B	$1.60B	$1.63B	$1.53B	$1.27B	$1.15B	$1.14B	$1.14B	$1.14B
Total assets	$7.37B	$7.12B	$6.90B	$6.63B	$5.75B	$6.05B	$6.07B	$5.65B	$5.43B	$5.23B	$5.20B	$5.19B
Total current liabilities	$1.43B	$1.33B	$1.32B	$1.54B	$1.59B	$1.79B	$1.17B	$1.41B	$1.34B	$1.21B	$1.19B	$1.22B
Short-term debt	$322.00M	$343.00M	$362.00M	$422.00M	$549.00M	$742.00M	$184.00M	$378.00M	$313.00M	$230.00M	$228.00M	$215.00M
Long-term debt	$1.80B	$1.75B	$1.74B	$1.79B	$1.59B	$1.59B	$2.22B	$2.02B	$2.02B	$2.01B	$2.00B	$1.99B
Total debt	$2.12B	$2.09B	$2.10B	$2.22B	$2.13B	$2.33B	$2.40B	$2.40B	$2.33B	$2.24B	$2.22B	$2.20B
Total liabilities	$4.08B	$3.87B	$3.83B	$4.14B	$3.81B	$4.04B	$4.11B	$4.17B	$4.09B	$3.91B	$3.85B	$3.84B
Shareholders' equity	$3.29B	$3.26B	$3.06B	$2.49B	$1.94B	$2.01B	$1.96B	$1.48B	$1.34B	$1.32B	$1.35B	$1.35B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$160.00M	$25.00M	$208.00M	$141.00M	$87.00M	$7.00M	$48.00M	$79.00M	$101.00M	$40.00M	$99.00M	$32.00M
Capital expenditures	$40.00M	$34.00M	$52.00M	$43.00M	$51.00M	$19.00M	$32.00M	$39.00M	$41.00M	$52.00M	$44.00M	$32.00M
Free cash flow	$120.00M	-$9.00M	$156.00M	$98.00M	$36.00M	-$12.00M	$16.00M	$40.00M	$60.00M	-$12.00M	$55.00M	$0
Investing cash flow	-$20.00M	-$43.00M	-$50.00M	-$47.00M	-$57.00M	-$17.00M	-$34.00M	-$36.00M	-$45.00M	-$53.00M	-$39.00M	-$43.00M
Financing cash flow	-$128.00M	-$14.00M	-$171.00M	-$79.00M	-$38.00M	$123.00M	-$68.00M	-$36.00M	-$99.00M	-$119.00M	-$11.00M	-$28.00M
Dividends paid	$30.00M	$29.00M	$33.00M	$33.00M	$31.00M	$32.00M	$32.00M	$32.00M	$32.00M	$32.00M	$0	$0
Share buybacks	$150.00M	$0	$150.00M	$100.00M	$0	—	—	$0	$0	—	—	$13.00M
Stock-based compensation	$13.00M	$11.00M	$12.00M	$12.00M	$4.00M	$10.00M	$9.00M	$6.00M	$8.00M	$8.00M	$9.00M	$8.00M
Depreciation & amortization	$33.00M	$86.00M	$86.00M	$89.00M	$88.00M	$79.00M	$88.00M	$92.00M	$93.00M	$79.00M	$85.00M	$82.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.